Clinical Trial Update: Effects of Duloxetine on Fear Conditioning in Posttraumatic Stress Disorder (PTSD) [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 study evaluated the effects of duloxetine on fear conditioning in individuals with Posttraumatic Stress Disorder. The trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttraumatic Stress Disorder

Drugs mentioned

• Duloxetine (DULOXETINE)

Snippet

Sponsor: Yale University | Conditions: Posttraumatic Stress Disorder | EARLY_Phase 1 | Status: COMPLETED